The next ph iii would probably come in before the FDA rules on the NDA. Logic doesn't fully hold.
Now that is the answer. I was wondering when you were going to get to that. I knew that was the scenario but don't like the fact that they weren't honest about it. They know it can't get approved on the data they have, and I think you know it also. They will file half-assed results, but if the next phase 3 works they will submit the data before the pdufa date.
Of course since forest is cheap they are only putting 800 people in the next phase 3 even though the trial that worked had 1200 people. the trial that failed had 880 people.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.